C12N 15/65
Using markers
Official title: using markers (enzymes used as markers C12N15/52)
C12N15/65 (Using markers) appears on 288 US grants and 361 published applications in this corpus.
Search patents in C12N- Granted patents
- 288
- Published applications
- 361
- Assignees
- 279
- Inventors
- 974
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 6 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 6 | 0 |
| 1996 | 5 | 0 |
| 1997 | 7 | 0 |
| 1998 | 8 | 0 |
| 1999 | 11 | 0 |
| 2000 | 21 | 0 |
| 2001 | 11 | 1 |
| 2002 | 7 | 11 |
| 2003 | 10 | 14 |
| 2004 | 5 | 13 |
| 2005 | 10 | 16 |
| 2006 | 6 | 7 |
| 2007 | 5 | 11 |
| 2008 | 6 | 7 |
| 2009 | 0 | 10 |
| 2010 | 3 | 5 |
| 2011 | 5 | 6 |
| 2012 | 7 | 13 |
| 2013 | 8 | 10 |
| 2014 | 5 | 12 |
| 2015 | 5 | 8 |
| 2016 | 9 | 13 |
| 2017 | 4 | 9 |
| 2018 | 9 | 18 |
| 2019 | 9 | 28 |
| 2020 | 10 | 27 |
| 2021 | 17 | 24 |
| 2022 | 14 | 18 |
| 2023 | 9 | 25 |
| 2024 | 12 | 17 |
| 2025 | 17 | 26 |
| 2026 | 8 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for inducing targeted meiotic recombinations1 Sep 2026US 12,723,267 B2Centre National De La Recherche Scientifique
- Method of assessing activity of recombinant antigen receptors11 Aug 2026US 12,703,734 B2Juno Therapeutics, Inc.
- DNA construct for diagnosing and treating cancer26 May 2026US 12,637,688 B2
- Lentiviral vector transfer plasmid and methods of use3 Feb 2026US 12,540,336 B2The Medical College of Wisconsin, Inc.
- Cell based shear stress sensor3 Feb 2026US 12,540,362 B2Sartorius Stedim Biotech GmbH
- Vectors expressing color and selectable markers17 Sep 2026US 2026/0275329 A1The Trustees of Indiana University
- Nucleic acid, recombinant vector, targeted integrated cell, gene expression method, and use13 Aug 2026US 2026/0234656 A1Shenzhen Taili Biotechnology Co., Ltd
- Glutamine synthetase marker for recombinant expression6 Aug 2026US 2026/0226524 A1Shanghai ZhenGe Biotechnology Co., Ltd.
- Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds23 Jul 2026US 2026/0209283 A1Amyris, Inc.
- Materials and methods for characterizing potency23 Jul 2026US 2026/0209795 A1Encoded Therapeutics, Inc.
Most cited
By later US patents
- Surface expression libraries of heteromeric receptors586US 5,698,426 AIxsys, Inc. · 1997
- Uses of green-fluorescent protein364US 5,491,084 AThe Trustees of Columbia University in the City of New York · 1996
- Modified green fluorescent proteins188US 5,625,048 AThe Regents of the University of California · 1997
- Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories178US 6,001,564 AInfectio Diagnostic, Inc. · 1999
- Cells homozygous for disrupted target loci148US 5,589,369 ACell Genesys, Inc. · 1996